The British Office of Fair Trading thinks that the NHS is paying too much for the wrong drugs and has put out a position paper as to how to tackle the problem. They suggest the current system of price and profit controls with a value based system. I am unsure if I agree entirely with their thinking, and admit I have yet to get all the way through the 120 page document (PDF) but it is not surprising that big pharma is less than pleased with their ideas with a spokesman for the Association of the British Pharmaceutical Industry saying that the organisation "strongly refuted suggestions that the NHS is paying too much for its drugs".
No comments:
Post a Comment